Indian pharma major Zydus Cadila's indigenous DNA Covid-19 vaccine, ZyCoV-D, is likely to be launched on 2 October, the birthday of Mahatma Gandhi.
The final meeting between the government and Zydus over the pricing of the vaccine is expected to happen this week, sources were quoted by the Economic Times as saying.
"The company was asked to submit the details regarding the cost. The negotiations are on and a decision will be taken soon," one of the source said.
ZyCoV-D is India's first vaccine that has been approved for children above 12 years of age.
The vaccine is likely to cost more than Covishield but will be comparable with those already approved, they said.
The pricing of the vaccine will be decided at a meeting between company representatives and the National Expert Group in Vaccine Administration for Covid (NEGVAC), headed by NITI Aayog member VK Paul, and health ministry officials, the sources said. The meeting is likely to be held this week, they added.
Meanwhile, the first few batches of the ZyCoV-D has been cleared by the government's Central Drug Laboratory at Kasauli and preparations are in full swing for the roll out of the vaccine.
As you are no doubt aware, Swarajya is a media product that is directly dependent on support from its readers in the form of subscriptions. We do not have the muscle and backing of a large media conglomerate nor are we playing for the large advertisement sweep-stake.
Our business model is you and your subscription. And in challenging times like these, we need your support now more than ever.
We deliver over 10 - 15 high quality articles with expert insights and views. From 7AM in the morning to 10PM late night we operate to ensure you, the reader, get to see what is just right.
Becoming a Patron or a subscriber for as little as Rs 1200/year is the best way you can support our efforts.